Is it advantageous for a younger healthy person to get the coronavirus to build immunity to it?
No, for several reasons, says Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine.
While a protective antibody is generated in those who are infected, scientists are not yet sure whether that immunity will last for a short period of time, for years or for life. Some say the possibility of reinfection is very likely.
Moreover, a new federal health report says Americans of all ages have faced serious health complications amid the outbreak. Data from the Centers for Disease Control and Prevention show that among the roughly 12% of COVID-19 cases in the U.S. known to need hospitalizations, about 1 in 5 were among people ages 20 to 44. Anywhere from 14% to 21% of adults ages 20 to 44 with COVID-19 have been hospitalized, the CDC data estimates. Two to 4% of cases led to ICU admissions, and less than 1% were fatal.